Chaitanya Devendra – Axxelent Pharma Science Pvt Ltd
View Detailed Executive Profile →Professional Overview
- Chaitanya Devendra co-founded Axxelent Pharma Science Pvt Ltd in April 2022, taking on the role of Chief Business Officer, demonstrating leadership and entrepreneurial spirit in the pharmaceutical sector.
- In addition to Axxelent, Chaitanya founded Avanthiya Pharma in September 2021, an initiative aimed at expanding capabilities and offerings in the pharmaceutical industry.
- Previously held the position of Head - Global Sales & Marketing for Ibuprofen & Derivatives at Solara Active Pharma Sciences from November 2015 until September 2021, where responsibilities included strategizing global sales efforts and expanding market outreach.
- Served as Associate Vice President at Solara Active Pharma Sciences from August 2019 to August 2021, indicating a progressive leadership role focused on enhancing business operations and market performance.
- Worked in Business Development at Shasun from June 2009 to September 2021, contributing to strategic partnerships and driving business growth in competitive environments.
- Axxelent Pharma Science Pvt Ltd aims to innovate within the pharmaceutical landscape, with Chaitanya orchestrating key business strategies and operational frameworks.
- Achievements in previous roles at Solara include successfully launching and marketing products globally while managing extensive sales teams, set against the backdrop of industry challenges such as market saturation and regulatory compliance.
- Chaitanya has consistently focused on creating sustainable growth opportunities and fostering collaborations that enhance product distribution and research initiatives.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Solara Active Pharma Sciences | Head - Global Sales & Marketing- Ibuprofen & Derivatives | Nov 2015 – Sep 2021 |
| Shasun | Business Development | Jun 2009 – Sep 2021 |
| Solara Active Pharma Sciences | Associate Vice President | Aug 2019 – Aug 2021 |
| Avanthiya Pharma | Founder | Sep 2021 – Present |
| Axxelent Pharma Science Pvt Ltd | Co- Founder and Chief Business Officer | Apr 2022 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Axxelent Pharma Science Pvt Ltd corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Chaitanya Devendra's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Axxelent Pharma Science Pvt Ltd's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)